Kevin Norman

Kevin Norman, PhD, is a consultant at Back Bay Life Science Advisors. Dr. Norman works with Back Bay’s integrated team of strategy consultants and investment banking professionals to support biopharma and medtech development across the life sciences industry.

Prior to joining Back Bay in 2021, Dr. Norman conducted clinical and preclinical research at Tufts University, McLean Hospital of Harvard Medical School, and Icahn School of Medicine at Mount Sinai leading to 10+ peer reviewed scientific publications. He has expertise in a range of neuro/CNS indications including autism, drug addiction, and depression. Kevin also has experience performing market research in the digital health space and conducting scientific due diligence on surgical products for a life science angel investment firm.

Dr. Norman received his PhD in Neuroscience from the Icahn School of Medicine at Mount Sinai and a BS in Biopsychology from Tufts University.